pentoxifylline has been researched along with Hypertrophy, Left Ventricular in 1 studies
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badenhorst, D | 1 |
| Anamourlis, C | 1 |
| Gibbs, M | 1 |
| Maseko, M | 1 |
| Osadchii, O | 1 |
| Woodiwiss, AJ | 1 |
| Norton, GR | 1 |
1 other study available for pentoxifylline and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
A phosphodiesterase inhibitor promotes the premature development of adverse cardiac remodelling mediated by beta-adrenergic activation in hypertension.
Topics: Adrenergic beta-Agonists; Animals; Collagen; Dilatation, Pathologic; Drug Therapy, Combination; Echo | 2004 |